TP53 and cancer: Other studies using CRISPR genetic engineering of cancer-related genes such as TP53, BRCA1, NF1, and PTEN support the premise that engineered FTE and OSE cells can acquire tumorigenic features, suggesting that HGSOC arises from either the ovary or the fallopian tube (23, 24).